Controlling levels of transcription is of central importance to all aspects of life. Indeed, the regulatory regions of higher eukaryotic promoters are frequently larger than the genes that they control with multiple binding sites for many distinct regulatory proteins that act in concert to orchestrate levels of transcription and, therefore, protein production in cells. To fully understand mammalian growth and development it is essential that we obtain a detailed understanding of the molecular mechanisms governing transcriptional regulation. To study the regulation of human mRNA synthesis we will apply kinetic experiments in a reconstituted transcription system for an entirely natural promoter. This unique approach is critical because of the importance of promoter sequence and architecture in the proper regulation of transcription. We reconstituted an in vitro system for studying the activation of transcription at the promoter of the human interleukin-2 gene. IL-2 is a key signaling molecule in the mammalian immune response. The IL-2 promoter is complex but compact and is perfectly suited to mechanistic studies in vitro and to controlled examination in cultured T lymphocytes. We have expressed and purified transcriptional activators, including NFATp, cJun, cFos; we have identified activator- coactivator interactions; and we have established transcriptional activation at the IL-2 promoter in vitro. We are now poised to perform kinetic studies on the regulation of transcription at the natural human IL-2 promoter. Another aspect of the proposed research is that we will evaluate the function of activator-coactivator interactions in IL-2 transcriptional activation in cultured human T lymphocytes. It is critical to test in vitro observations in the context of cells, since a reconstituted in vitro transcription system lacks some factors that affect transcriptional regulation, such as nucleosomes, post- translational modifications, and perhaps yet unidentified proteins or cofactors. Our studies will provide detailed insight into the mechanism of transcriptional regulation at a natural promoter that is of great importance to the development of the human immune system.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM055235-03
Application #
6180652
Study Section
Molecular Biology Study Section (MBY)
Program Officer
Marino, Pamela
Project Start
1998-08-01
Project End
2002-07-31
Budget Start
2000-08-01
Budget End
2001-07-31
Support Year
3
Fiscal Year
2000
Total Cost
$194,426
Indirect Cost
Name
University of Colorado at Boulder
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
City
Boulder
State
CO
Country
United States
Zip Code
80309
Walters, Ryan D; Drullinger, Linda F; Kugel, Jennifer F et al. (2013) NFATc2 recruits cJun homodimers to an NFAT site to synergistically activate interleukin-2 transcription. Mol Immunol 56:48-56
Nguyen, Tuan N; Kim, Loree J; Walters, Ryan D et al. (2010) The C-terminal region of human NFATc2 binds cJun to synergistically activate interleukin-2 transcription. Mol Immunol 47:2314-22
Goodrich, James A; Kugel, Jennifer F (2010) Genome-wide insights into eukaryotic transcriptional control. Genome Biol 11:305
Goodrich, James A; Tjian, Robert (2010) Unexpected roles for core promoter recognition factors in cell-type-specific transcription and gene regulation. Nat Rev Genet 11:549-58
Kugel, Jennifer F; Goodrich, James A (2009) In new company: U1 snRNA associates with TAF15. EMBO Rep 10:454-6
Weaver, Jessica R; Good, Kristi; Walters, Ryan D et al. (2007) Characterization of the sequence and architectural constraints of the regulatory and core regions of the human interleukin-2 promoter. Mol Immunol 44:2813-9
Hieb, Aaron R; Baran, Sean; Goodrich, James A et al. (2006) An 8 nt RNA triggers a rate-limiting shift of RNA polymerase II complexes into elongation. EMBO J 25:3100-9
Nguyen, Tuan N; Goodrich, James A (2006) Protein-protein interaction assays: eliminating false positive interactions. Nat Methods 3:135-9